[1]郑晓菊,黄 静,廖友鑫,等.基于DRG病组的临床路径管理实践探索[J].卫生经济研究,2024,41(12):24-28.
　ZHENG Xiaoju,HUANG Jing,LIAO Youxin,et al.Exploration of Clinical Pathway Management Practice based on DRG Disease Group[J].Journal Press of Health Economics Research,2024,41(12):24-28.
点击复制

基于DRG病组的临床路径管理实践探索
分享到：

卫生经济研究[ISSN:1004-7778/CN:33-1056/F]

卷:
41
期数:
2024年12期
页码:
24-28
栏目:
专题研究
出版日期:
2024-12-03

文章信息/Info

Title:
Exploration of Clinical Pathway Management Practice based on DRG Disease Group
作者:
郑晓菊1; 黄 静1; 廖友鑫1; 陶 洲1; 曹 洁1
1.重庆大学附属江津医院，重庆市江津区中心医院，重庆 402260
Author(s):
ZHENG Xiaoju;  HUANG Jing;  LIAO Youxin;  TAO Zhou;  CAO Jie
Jiangjin Hospital Affiliated to Chongqing University, Jiangjin Central Hospital of Chongqing, Chongqing 402260, China
关键词:
临床路径; DRG病组; 医疗资源消耗
Keywords:
clinical pathway;  DRG disease group;  medical resource consumption
分类号:
R197.3
文献标志码:
A
摘要:
目的：总结基于DRG病组的临床路径管理实践及成效，为DRG支付下优化临床路径管理提供实证参考。方法：选取样本医院6个常见病种1 997个病例数据，分为传统临床路径组（TCP）和基于DRG病组的临床路径组（CP-DRG），分析两组临床路径管理评价指标、医疗资源消耗指标、医疗资源消耗指标变异系数的差异。结果：与TCP组比较，6个病种CP-DRG组路径完成率升高，变异率和退出率降低，但仅脑梗死的两组差异有统计学意义；CP-DRG组在管控平均住院日、次均住院费用、药占比、耗占比方面的优势突出。结论：在传统临床路径的基础上，结合DRG病组建立的临床路径，在提升路径管理效果、节约医疗资源消耗方面具有一定的优势。
Abstract:
Objective To summarize the practice and effectiveness of clinical pathway management based on DRG disease group, and to provide empirical references for optimizing clinical pathway management under DRG payment. Methods 1 997 case data of 6 common diseases in the sample hospital were selected and divided into traditional clinical pathway group(TCP) and clinical pathway group based on DRG disease group(CP-DRG), and the differences in evaluation indexes of clinical pathway management, consumption indexes of medical resources, and coefficients of variation of medical resource consumption indexes were analyzed between the two groups. Results Compared with the TCP group, the pathway completion rate of the CP-DRG group for the six disease groups increased, and the coefficient of variation and dropout rate decreased, but the difference between the two groups was statistically significant only for the path completion rate of cerebral infarction. The CP-DRG group was superior to the TCP group in average hospitalization days, average hospitalization expenses, average drug proportion and average consumption proportion. Conclusion On the basis of traditional clinical pathway, the clinical pathway based on DRG disease group has certain advantages in improving the effect of pathway management and saving medical resource consumption.

参考文献/References:

[1] 杨翼帆，王淑慧，杨凡，等.DRG支付方式下医院管理模式探索[J].中国卫生标准管理，2021，12（03）：25-28.
[2] PhD(C) M R H A Z,MSN R H X L.Clinical pathways: effects on professional practice, patient outcomes,length of stay and hospital costs[J].International Journal of Evidence-Based Healthcare,2011,9(02)：191-192.
[3] Anke W,Christopher L D V ,Elmar H, et al. Patient involvement in clinical pathway development,implementation and evaluation——A scoping review of international literature[J].Patient Education and Counseling,2021,105(06)：1411-1448.
[4] 段光荣.建立基于DRG工具的管理闭环[J].中国卫生，2021（01）：64-66.
[5] 李梦滢，孙志成，唐尧，等.基于DRG的公立医院临床路径管理体系建设[J].卫生经济研究，2022，39（02）：67-69，74.
[6] 宋晴雯，朱健倩.基于DRGs的临床路径实施与质量评价研究[J].医院管理论坛，2019，36（10）：15-19.
[7] 彭皓均，涂淮，王文静，等.中风急性期中医临床路径应用前后情况回顾性分析[J].广州中医药大学学报，2017，34（06）：805-809.
[8] 林家荣，苏智军，郑辉明，等.不同DRGs分组患者临床路径管理效果分析[J].中华医院管理杂志，2019，35（07）：548-553.
[9] 白飞，白洁，汤慧芹，等.公立医院临床路径实施病种数影响因素分析[J].中华医院管理杂志，2017，33（01）：27-29.
[10] Hiroki F,Kenji A,Taisuke O,et al.Effect on completion of clinical pathway for improving clinical indicator:cases of hospital stay,mortality rate,and comprehensive-volume ratio[J].Journal of Medical Systems,2017,41(12)：206.
[11] 古德彬，李梦滢，沈际勇.临床路径管理对脑梗死患者住院费用的影响研究[J].卫生经济研究，2023，40（06）：30-34.

相似文献/References:

[1]裴 敬,周晓容,李家伟,等.新农合单病种支付方式改革现状与对策研究[J].卫生经济研究,2017,(01):32.
[2]肖云芳,何 宇,杨小丽.医养结合发展热潮的冷思考[J].卫生经济研究,2017,(08):22.
[3]于保荣.按病例支付及医疗服务支付方式改革的实现条件——从DRGs、按病种付费、点数法付费及临床路径谈起[J].卫生经济研究,2018,(09):16.
　YU Bao-rong.Conditions for the Implementation of Reforms by Case Payment and Payment for Medical Services ——From DRGs，Case-based payments，Point payments，and Clinical pathways[J].Journal Press of Health Economics Research,2018,(12):16.
[4]张文娟,宋厚斌,王新虹,等.基于临床路径的按病种付费分段控制标准化构建[J].卫生经济研究,2019,(07):36.
　ZHANG Wen-juan,SONG Hou-bin,WANG Xin-hong,et al.Standardized Construction of Disease-based Segmentation Control Based on Clinical Path[J].Journal Press of Health Economics Research,2019,(12):36.
[5]陈佳颖,吴丹枫.医院病种成本核算方法研究及应用[J].卫生经济研究,2020,(03):46.
　CHEN Jia-ying,WU Dan-feng.Research and Application of Hospital Disease Cost Accounting Method[J].Journal Press of Health Economics Research,2020,(12):46.
[6]向 前,吴荣海,吴伟旋,等.基于临床路径的病种标准成本核算研究[J].卫生经济研究,2020,(10):66.
　XIANG Qian,WU Rong-hai,WU Wei-xuan,et al.Research on the Standard Cost Accounting of Disease Based on Clinical Pathway[J].Journal Press of Health Economics Research,2020,(12):66.
[7]陈新平,吴月红,诸葛丽.公立医院DRG病组成本核算探析[J].卫生经济研究,2021,38(6):72.
　CHEN Xin-ping,WU Yue-hong,ZHU GE-Li.Analysis on Cost Accounting of DRG in Public Hospitals[J].Journal Press of Health Economics Research,2021,38(12):72.
[8]李梦滢,孙志成,唐 尧,等.基于DRG的公立医院临床路径管理体系建设[J].卫生经济研究,2022,39(2):67.
　LI Meng-ying,SUN Zhi-cheng,TANG Yao,et al.Construction of Clinical Pathway Management System in Public Hospitals Based on DRG[J].Journal Press of Health Economics Research,2022,39(12):67.
[9]纪 门,孔旭辉,黄秀芹,等.DRG高倍率病例特征分析及管理建议[J].卫生经济研究,2023,40(1):78.
　JI Men,KONG Xuhui,HUANG Xiuqin,et al.Cause Analysis and Policy Optimization of DRG High-Rate Cases[J].Journal Press of Health Economics Research,2023,40(12):78.
[10]古德彬,李梦滢,沈际勇.临床路径管理对脑梗死患者住院费用的影响研究[J].卫生经济研究,2023,40(6):30.
　GU Debin,LI Mengying,SHEN Jiyong.Study on the Influence of Clinical Pathway Management on Hospitalization Expenses of Patients with Cerebral Infarction[J].Journal Press of Health Economics Research,2023,40(12):30.

更新日期/Last Update: 2024-12-03